Optimizing chemotherapy and targeted agent combinations in NSCLC

T Lynch Jr, E Kim - Lung Cancer, 2005 - Elsevier
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

Optimizing chemotherapy and targeted agent combinations in NSCLC

T Lynch, E Kim - Lung Cancer, 2005 - lungcancerjournal.info
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

[引用][C] Optimizing chemotherapy and targeted agent combinations in NSCLC

TJR LYNCH, E KIM - Lung cancer, 2005 - pascal-francis.inist.fr
Optimizing chemotherapy and targeted agent combinations in NSCLC CNRS Inist Pascal-Francis
CNRS Pascal and Francis Bibliographic Databases Simple search Advanced search Search …

Optimizing chemotherapy and targeted agent combinations in NSCLC.

T Lynch Jr, E Kim - Lung Cancer (Amsterdam, Netherlands), 2005 - europepmc.org
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

Optimizing chemotherapy and targeted agent combinations in NSCLC

T Lynch Jr, E Kim - Lung cancer (Amsterdam, Netherlands …, 2005 - pubmed.ncbi.nlm.nih.gov
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

Optimizing chemotherapy and targeted agent combinations in NSCLC

T Lynch, E Kim - Lung Cancer, 2005 - infona.pl
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

Optimizing chemotherapy and targeted agent combinations in NSCLC.

T Lynch Jr, E Kim - Lung Cancer (Amsterdam, Netherlands), 2005 - europepmc.org
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

Optimizing chemotherapy and targeted agent combinations in NSCLC

T Lynch Jr, E Kim - Lung cancer (Amsterdam, Netherlands …, 2005 - pubmed.ncbi.nlm.nih.gov
Chemotherapy extends life and provides symptom palliation for patients with advanced non-
small cell lung cancer (NSCLC). Numerous trials have been conducted that evaluate a …

[引用][C] Optimizing chemotherapy and targeted agent combinations in NSCLC

TJR LYNCH, E KIM - Lung cancer, 2005 - Elsevier